Ignite Creation Date:
2024-05-05 @ 9:57 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00003820
Status:
COMPLETED
Last Update Posted:
2017-04-20
First Post:
1999-11-01
Brief Title:
Rituximab in Treating Patients With Hodgkins Lymphoma
Sponsor:
Ranjana Advani
Organization:
Stanford University
Organization Data
Organization:
Stanford University
Class:
OTHER
Study ID:
IRB-13452
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ranjana Advani
Lead Sponsor Class:
OTHER
Responsible Party:
Ranjana Advani
Responsible Party Title:
Saul A Rosenberg MD Professor of Lymphoma
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Stanford University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Genentech Inc | INDUSTRY |